04.05.2012
Kemira has opened a Research & Development projects laboratory in Alberta, Canada on May 1, 2012. The laboratory, located on the campus of the University of Alberta, will be an extension of Kemira's North American R&D, headquartered in Atlanta.
The new site also supports Kemira's regional growth in the conventional oil and gas marketplace, e.g. stimulation, drilling and cementing.
more02.04.2012
In a nondescript suburb south of London, tucked away behind a big hospital, Paul Workman and fellow scientists are celebrating victory in the "World Cup" of cancer drug research for their work in discovering a stream of new medicines.
But the win is bitter-sweet. One of the new drugs behind the coveted prize from the American Association for Cancer Research (AACR) has been deemed too costly to use in state-run British hospitals like the one next door.
It is a stark example of the pricing crisis now facing cancer medicines across the globe.
more23.03.2012
Evonik Industries and the Leibniz Institute for Catalysis (LIKAT) are planning to expand their cooperation in the area of catalysis research for the long term. The Institute has been successfully working with Evonik in the field of catalysis for more than ten years and the parties recently agreed to extend their long-term cooperation.
more18.03.2011
U.S. biotech company Genzyme said on Thursday it planned joint research projects with Russian high-tech centre ChemRar, joining a growing number of global drugmakers seeking to gain a local presence.
Establishing a presence is a way for international drug companies to secure guaranteed sales in Russia, which wants to reduce dependence on imported drugs.
more16.12.2010
Swiss specialty chemicals company Clariant is planning to expand its global research and development (R&D) activities at its site in Frankfurt, Germany. The new, 23,000 m2 Clariant Innovation Center is due to be completed by the end of 2012. It will provide space for 500 people.
more14.12.2010
Sanofi-Aventis named Elias Zerhouni as its new head of research and development as the French drugmaker reshapes its drug portfolio to offset sales losses from patent expiries.
Sanofi said on Tuesday Zerhouni, appointed as scientific adviser to Chief Executive Chris Viehbacher in 2009, had been "instrumental in redesigning the R&D model to foster increased innovation, the first pillar of the group's strategy."
Zerhouni will take over from Marc Cluzel as of Jan. 1 next year, Sanofi said in a statement on Tuesday. Cluzel will stay as a scientific expert to Zerhouni.
more15.10.2010
Clariant announced that it will be relocating the headquarters of its Textile Chemicals business unit to Singapore. The company said the move, which is due to be completed by mid 2011, will place the BU's management team closer to its global customers and "at the heart of the world's main textile markets." The decision to move the unit to Asia was announced in February and was met with protests from Unia trade-union workers.
more15.07.2010
BASF Coatings and Henkel have signed a joint venture agreement to develop innovative corrosion protection solutions for the automotive industry. The 50/50 venture, pending approval of the German anti-trust authorities, will be headquartered in Düsseldorf. The joint venture is anticipated to launch in early 2011.
more26.05.2010
Accelrys has announced the release of Accelrys Pipeline Pilot 8.0. This latest release of Accelrys' scientific informatics platform has been further developed to support a greater number of scientists and researchers working individually or as collaborative teams across the wider scientific R&D enterprise.
more02.04.2010
Launched at Analytica, the latest shaking incubator from Stuart is specially designed for use with microtitre plates to meet the needs of life science labs. Offering the ideal shaking action for mixing very small volumes in well plates or micro tubes, the SI505 also dramatically reduces sample evaporation and features state-of-the-art microprocessor detection, setting and control of temperature.
more